141 related articles for article (PubMed ID: 3742049)
1. Effect of danazol on clotting factor levels, bleeding incidence, factor infusion requirements, and immune parameters in hemophilia.
Saidi P; Lega BZ; Kim HC; Raska K
Blood; 1986 Sep; 68(3):673-9. PubMed ID: 3742049
[TBL] [Abstract][Full Text] [Related]
2. Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B.
Nugent DJ; Bray GL; Counts RB; Clements MJ; Thompson AR
Br J Haematol; 1986 Nov; 64(3):493-502. PubMed ID: 3098273
[TBL] [Abstract][Full Text] [Related]
3. Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.
Gralnick HR; Rick ME
N Engl J Med; 1983 Jun; 308(23):1393-5. PubMed ID: 6405274
[TBL] [Abstract][Full Text] [Related]
4. Effect of danazol on coagulation parameters and bleeding in hemophilia.
Garewal HS; Corrigan JJ; Durie BG; Jeter MA; Damiano ML
JAMA; 1985 Feb; 253(8):1154-6. PubMed ID: 3968845
[TBL] [Abstract][Full Text] [Related]
5. Benefits of danazol treatment in patients with hemophilia A (classic hemophilia).
Gralnick HR; Maisonneuve P; Sultan Y; Rick ME
JAMA; 1985 Feb; 253(8):1151-3. PubMed ID: 3918188
[TBL] [Abstract][Full Text] [Related]
6. Danazol therapy in haemophilia.
Heaton DC; Wyld PJ; Conder JL
N Z Med J; 1986 Mar; 99(798):185-7. PubMed ID: 3517712
[TBL] [Abstract][Full Text] [Related]
7. Danazol-induced factor VIII and IX bypassing activity in hemophiliacs.
Garewal HS; Corrigan JJ; Jeter MA; Damiano ML; Durie BG
Thromb Res; 1985 Jul; 39(1):117-25. PubMed ID: 3929420
[TBL] [Abstract][Full Text] [Related]
8. Poor response to danazol in hemophilia.
Kasper CK; Boylen AL
Blood; 1985 Jan; 65(1):211-3. PubMed ID: 3917312
[TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled double-blind study of danazol in hemophilia A.
Mehta J; Singhal S; Kamath MV; Mehta BC
Acta Haematol; 1992; 88(1):14-6. PubMed ID: 1414156
[TBL] [Abstract][Full Text] [Related]
10. Effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats.
Nobukata H; Katsuki Y; Ishikawa T; Inokuma M; Shibutani Y
Toxicol Lett; 1999 Jan; 104(1-2):93-101. PubMed ID: 10048754
[TBL] [Abstract][Full Text] [Related]
11. Danazol in hemophilia.
Ambriz R; Pizzuto J; Guillen C
JAMA; 1985 Aug; 254(6):754-5. PubMed ID: 4009909
[No Abstract] [Full Text] [Related]
12. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
[TBL] [Abstract][Full Text] [Related]
13. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
Stobart K; Iorio A; Wu JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
[TBL] [Abstract][Full Text] [Related]
14. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
[TBL] [Abstract][Full Text] [Related]
15. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters.
Tuinenburg A; Biere-Rafi S; Peters M; Verhamme P; Peerlinck K; Kruip MJ; Laros-Van Gorkom BA; Roest M; Meijers JC; Kamphuisen PW; Schutgens RE
Haemophilia; 2013 Sep; 19(5):744-52. PubMed ID: 23659471
[TBL] [Abstract][Full Text] [Related]
16. Danazol and hemophilia.
Hathaway WE
JAMA; 1985 Feb; 253(8):1167. PubMed ID: 3968846
[No Abstract] [Full Text] [Related]
17. Danazol in Indian haemophiliacs.
Sundar S; Moorleedhur-Singh GS; Dube B; Singh VP; Kumar K
J Assoc Physicians India; 1993 Jan; 41(1):23-5. PubMed ID: 8340322
[TBL] [Abstract][Full Text] [Related]
18. Longer-acting clotting factor concentrates for hemophilia.
Powell JS
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S167-75. PubMed ID: 26149018
[TBL] [Abstract][Full Text] [Related]
19. Strategies for Individualized Dosing of Clotting Factor Concentrates and Desmopressin in Hemophilia A and B.
Preijers T; Schütte LM; Kruip MJHA; Cnossen MH; Leebeek FWG; van Hest RM; Mathôt RAA
Ther Drug Monit; 2019 Apr; 41(2):192-212. PubMed ID: 30883513
[TBL] [Abstract][Full Text] [Related]
20. Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII.
Zollner SB; Raquet E; Müller-Cohrs J; Metzner HJ; Weimer T; Pragst I; Dickneite G; Schulte S
Thromb Res; 2013 Aug; 132(2):280-7. PubMed ID: 23830969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
